Evidence map›Paper›PMID 37454248›Full record

ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2023

Effect of Traditional Chinese Medicine combined with Western Medicine on blood lipid levels and inflammatory factors in patients with angina pectoris in coronary heart disease identified as intermingled phlegm and blood stasis syndrome: a network Meta-analysis.

Wang Chao, W U Qiong, L I Ping, Wang Zhigang, Lou Xusheng, L I Yuanyuan, Zhang Lin

Open access · greenAbstract readNetwork Meta-Analysis
In one paragraph

Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Wang ChaoPostdoctoral Mobile Station of Chinese Academy of Traditional Chinese medicine, Beijing 100700, China.
W U QiongZang-xiang Teaching and Research Department, the Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
L I PingDepartment of Cardiovascular Medicine Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China.
Wang ZhigangShandong College of Traditional Chinese Medicine, Yantai 264199, China.
Lou XushengDepartment of Cardiovascular Medicine Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China.
L I YuanyuanDepartment of Cardiovascular Medicine Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China.
Zhang LinSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China.
Beijing University of Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Fundamental Research Funds for the Central Public Welfare Research Institutes: Theoretical Study of Combination of Facial Color and Pulses Mode in Traditional Chinese Medicine KJ-202013Objective Study of "Wei Qi" in Pulse Based on Color Doppler Flow Imaging (CDFI) Technology YZ-202124
6 · The paper itself

Abstract

objectiveTo evaluate the clinical efficacy of Traditional Chinese Medicine prescriptions for resolving phlegm in the treatment of angina pectoris of phlegm-stasis coronary heart disease by a network Meta-analysis.

methodsRandomized controlled trials (RCTs) on clinical efficacy of CHD angina pectoris with interaction of phlegm and blood stasis were searched in PubMed, Springer, the Cochrane Library and Chinese-language databases China National Knowledge Infrastructure, China Science and Technology Journal Database, and Wanfang Data from their inception to December 2021. Literature was screened and literature bias risk was assessed by RevMan5.4 software. The overall response rate, the duration of angina attack, the levels of serum lipids such as total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C), and expression of hypersensitive C-reactive protein (hs-CRP) were selected as outcome indicators for network Meta-analysis and mapped using Stata15.1 software.

resultsTotally, 26 RCTs were included, involving 2098 participants. There were 6 TCM formulas with the effects of dispelling phlegm and removing blood stasis. Taking conventional Western Medicine as the common intervention measures, the results showed that the overall response improvement rate from high to low was displayed as modified Xiaoxianxiong decoction (, MXD), Danlou tablet (, DT), modified Gualou Xiebai Banxia decoction (, MGXBD), modified Wendan decoction (, MWD), modified Zhishi Xiebai Guizhi decoction (, MZXGD), and modified Erchen decoction (, MED). The sequence of angina attack duration improvement from high to low was MZXGD, MGXBD, DT, MWD, MXD. The sequence of TC improvement from high to low was MZXGD, MED, DT, and MGXBD. Sequence of improving TG from high to low was MED, MZXGD, MGXBD, and DT. For LDL-C improvement, the effect from good to poor was MZXGD, MGXBD, DT, and MED. With regard to HDL-C improvement, the effect was ranked as MED, MZXGD, MGXBD, and DT from good to poor. hs-CRP expression from high to low was MZXGD, MXD, MED, MWD, and MGXBD.

conclusionTCM formula with the effects of dispelling phlegm and removing blood stasis combined with conventional Western Medicine has obvious advantages in treating CHD angina pectoris with interaction of phlegm and blood stasis. MZXGD has great potential in increasing the overall response rate, reducing Duration of angina attack improving blood lipids, and reducing inflammatory factors. However, due to the limitations of extant studies, the conclusions of this study need to be confirmed by numerous reasonably-designed RCTs.

Indexed as

Coronary DiseaseDrugs, Chinese HerbalAngina PectorisCholesterol, LDLC-Reactive ProteinHumansLipidsMedicine, Chinese TraditionalTriglyceridesCholesterol, LDLC-Reactive ProteinDrugs, Chinese Herbalgualou xiebai banxia decoctionLipidsTriglyceridesangina pectorisblood lipidcoronary diseaseinflammatory factorsmedicine, traditional Chinesenetwork Meta-analysisphlegm and blood stasis interactionrandomized controlled trial

Identifiers

PMID37454248
PMCPMC10320448
OpenAlexW4384466896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.